Most patients with GATA2-deficiency have been diagnosed with MDS, CMML/juvenile myelomonocytic leukemia, MDS/MPN overlap, AML and bone marrow failure (78.3%, n=508, Figure 2B). This evidence concerns the gene GATA2 and Bone marrow hypocellularity.